InVivo Therapeutics (NSDQ:NVIV) said today it inked a joint research agreement with clinical-stage central nervous system cell therapy developer Q Therapeutics. Through the deal, InVivo is looking to combine its neuro-spinal scaffold technology with Q Therapeutics’ adult neural progenitor cells, Cambridge, Mass.-based InVivo said. Both companies will share their technologies and explore the potential combination’s safety […]
